PART I ITEM 1. B USINESS Company Overview We are a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. On March 26, 2025, we announced that our lead product candidate, VYKAT TM XR (diazoxide choline) extended-release tablets, formerly known as DCCR, had been approved by the U.S. Food and Drug Administration (FDA). VYKAT XR is indicated to treat hyperphagia in adults and pediatric patients four years of age and older with Prader-Willi syndrome (PWS). On Apr...
Q2 FY2026 — expected 2026-09-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001193125-26-071808 | EDGAR | 73K words |
| 2025-02-28 | 2024-12-31 | 0000950170-25-029545 | EDGAR | — |
| 2024-03-07 | 2023-12-31 | 0000950170-24-027500 | EDGAR | — |
| 2023-03-22 | 2022-12-31 | 0000950170-23-009211 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001564590-22-013023 | EDGAR | — |
| 2021-03-03 | 2020-12-31 | 0001564590-21-010569 | EDGAR | — |
| 2020-03-04 | 2019-12-31 | 0001564590-20-008705 | EDGAR | — |
| 2019-03-20 | 2018-12-31 | 0001564590-19-008508 | EDGAR | — |
| 2018-04-02 | 2017-12-31 | 0001193125-18-104048 | EDGAR | — |
| 2017-03-15 | 2016-12-31 | 0001628280-17-002603 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-04 | 2025-09-30 | 0001193125-25-264941 | EDGAR | 51K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-104220 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000950170-25-065675 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122276 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092713 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-057109 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0000950170-23-060438 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0000950170-23-039934 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019752 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0000950170-22-023838 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001564590-22-028965 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001564590-22-019266 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-06 | 0001193125-26-142911 | EDGAR | 67K words |
| 2026-03-16 | 0001193125-26-107429 | EDGAR | — |
| 2026-02-26 | 0001193125-26-073209 | EDGAR | — |
| 2026-02-25 | 0001193125-26-071528 | EDGAR | — |
| 2026-01-23 | 0001193125-26-021229 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009886 | EDGAR | — |
| 2025-11-12 | 0001193125-25-275674 | EDGAR | — |
| 2025-11-04 | 0001193125-25-264658 | EDGAR | — |
| 2025-10-14 | 0001193125-25-237854 | EDGAR | — |
| 2025-09-10 | 0001193125-25-199882 | EDGAR | — |
255 total filings indexed. 223 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001484565 |
| Ticker | SLNO |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.soleno.life |
| Listed | 2014-11-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/SLNO (~200 tokens, structured JSON with cryptographic provenance)